Insider trade

Jupiter Neurosciences (JUNS): Director received 100K units

Allison W Brady, Director at Jupiter Neurosciences, reported a grant / award of 100K units.

100K
Derivative units
Traded
Jun 2, 2026
Filed
Jun 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 20, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  2. Jun 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 5, 2026, the Company entered into amendment No. 3 (the “Amendment”) to the employment agreement with Alison Silva, dated September 1, 2021, as amended. The Amendment appoints Ms. Silva as the Company’s Chief Operating Officer and President and increases Ms. Silva’s base salary to $340,200 from $315,000.”

What came next

  1. Jun 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 17, 2026, Allison W. Brady, a member of the Board of Directors (the “Board”) of Jupiter Neurosciences, Inc. (the “Company”), informed the Company of her decision to resign from the Board, effective immediately.”
  2. Jun 26, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 26, 2026, the Board of Directors (the “Board”) of Jupiter Neurosciences, Inc. (the “Company”) appointed Tomas J. Philipson, Ph.D. to serve as a member of the Board, effective immediately.”
  3. Jul 20, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
  4. Jul 28, 2026Company filing · Form 8-K · Unregistered shares, Other newsSold new shares without registering them, and reported other company news
  5. Aug 6, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year (and 1 more item)
  6. Aug 21, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  7. Aug 26, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement (and 1 more item)“The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.”
  8. Aug 27, 2026Company filing · Form 8-K · Listing notice, Other newsReceived a notice from its stock exchange, and reported other company news“On August 27, 2026, Jupiter Neurosciences, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff had determined to delist the Company’s common stock from The Nasdaq Capital Market.”
  9. Aug 28, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Jupiter Neurosciences

OQRO holds no insider, Congress, fund or contract record for Jupiter Neurosciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JUNS page.

How this filing works

Explore the data

Common questions

Which Jupiter Neurosciences (JUNS) insider traded, and how much?

Allison W Brady, Director at Jupiter Neurosciences, reported a grant / award of 100K units. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Jun 2, 2026. Filed: Jun 5, 2026. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean JUNS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Jupiter Neurosciences

Everything OQRO holds on this company is on its JUNS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data